Swiss National Bank
KRSA

Swiss National Bank’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Swiss National Bank’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-202
Closed -$75K – 2458
2020
Q1 		$75K Hold
202
– – ﹤0.01% 2476
2019
Q4 		$77K Hold
202
– – ﹤0.01% 2506
2019
Q3 		$342K Buy
202
+20
+11% +$4.32K ﹤0.01% 2438
2019
Q2 		$292K Buy
+182
New +$51.5K ﹤0.01% 2518

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's KRSA Position: Q2 2020 in Review

Swiss National Bank sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2020, closing a stake of 202 shares — an estimated $75K sold.

Swiss National Bank first reported a position in KRSA in Q2 2019 and held it in 4 quarters. The position peaked at $342K in Q3 2019. 70 funds tracked by Wall St. Rank hold KRSA as of Q2 2020.

  • Swiss National Bank reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Swiss National Bank sold 202 Korsana Biosciences, Inc. Common Stock shares in Q2 2020, an estimated $75K.
  • Swiss National Bank first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Swiss National Bank's Korsana Biosciences, Inc. Common Stock position peaked at $342K in Q3 2019.
  • 70 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2020.

Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.